Stock Comparison
HIT vs TDOC
Health In Tech Inc vs Teladoc Health Inc
The Verdict
HIT takes this one.
Head-to-Head
Market Cap
P/E Ratio
Profit Margin
Return on Equity
Overall Risk
DVR Score
The Deep Dive
Health In Tech (HIT) continues to exhibit strong 10x growth potential, validated by its Q4 and full-year 2025 results, which showed a significant 71% YoY revenue increase to $33.3 million and, critically, achieved full-year net profitability of $1.3 million. This transition from 'unprofitable' status is a material positive development, demonstrating execution on its AI-driven personalized preventi...
Full HIT AnalysisTeladoc Health operates in a vast and growing virtual care market, with a clear strategic vision centered on whole-person health and employer/payer partnerships, offering significant long-term potential (24/30). Financial discipline shows incremental improvement, focusing on cost controls and a clearer path to adjusted profitability, helping stabilize cash burn, but GAAP profitability remains elus...
Full TDOC AnalysisWant More Comparisons?
Run any stock through our deep value analyzer.
Analyze Any Stock →Not Financial Advice
This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.